Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in LDLR −/− Mice by Treatment With the ATP-Citrate Lyase Inhibitor Bempec AcidHighlights

Arteriosclerosis, Thrombosis, and Vascular Biology- United States

doi 10.1161/atvbaha.116.308963

Full Text

Abstract

Available in

Date

Authors

Publisher

Ovid Technologies (Wolters Kluwer Health)


Related search